9.22
[1]. Elder DP, et al. Pharmaceutical excipients - quality, regulatory and biopharmaceutical considerations. Eur J Pharm Sci. 201 May 25;87:88-99.
[2]. Essa E A. Effect of formulation and processing variables on the particle size of sorbitan monopalmitate niosomes[J]. Asian Journal of Pharmaceutics (AJP), 2010, 4(4).
[]. é Petró, et al. Drug release from semisolid dosage forms: a comparison of two testing methods. Pharm Dev Technol. 2015 May;20():0-.
[4]. J D Brandner, et al. The composition of NF-defined emulsifiers: sorbitan monolaurate, monopalmitate, monostearate, monooleate, polysorbate 20, polysorbate 40, polysorbate 0, and polysorbate 80. Drug Dev Ind Pharm. 1998 Nov;24(11):1049-54.
[5]. M Rabiskova, et al. The influence of surface properties on uptake of oil into complex coacervate microcapsules. J Pharm Pharmacol. 1994 Aug;4(8):1-5.
H02-H15-H19-H5
P21-P24-P270-P271-P280-P02+P52-P04+P40-P0-P2+P4-P405-P501